Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.)
|
|||
| Mailing Address: | 999 West Broadway Suite 720 Vancouver, British Columbia V5Z 1K5 |
Head Office Address: | 9920 Pacific Heights Blvd. Suite 150 San Diego, California 92121 |
| Contact Name: | Scott Praill | Principal Regulator: | British Columbia |
| Business e-mail address: | spraill@kintara.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 604 202-1384 | Reporting Jurisdictions: | British Columbia, Other than Canada |
| Fax Number: | 604 738-4080 | Stock Exchange: | NASDAQ |
| Date of Formation: | Jun 24 2009 | Stock Symbol: | KTRA |
| Jurisdiction Where Formed: | Nevada | Auditor: | Marcum LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 49720K | Transfer Agent: | Mountain Share Transfer, LLC |
| Financial Year-End: | Jun 30 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
